HUP0004590A2 - Endotelin-antagonista imidazolszármazékokat és béta receptor blokkolókat tartalmazó kombinációs gyógyszerkészítmények - Google Patents
Endotelin-antagonista imidazolszármazékokat és béta receptor blokkolókat tartalmazó kombinációs gyógyszerkészítményekInfo
- Publication number
- HUP0004590A2 HUP0004590A2 HU0004590A HUP0004590A HUP0004590A2 HU P0004590 A2 HUP0004590 A2 HU P0004590A2 HU 0004590 A HU0004590 A HU 0004590A HU P0004590 A HUP0004590 A HU P0004590A HU P0004590 A2 HUP0004590 A2 HU P0004590A2
- Authority
- HU
- Hungary
- Prior art keywords
- beta receptor
- endothelin antagonist
- pharmaceutical preparations
- blocking agents
- imidazole derivatives
- Prior art date
Links
- 239000002876 beta blocker Substances 0.000 title abstract 2
- 239000002308 endothelin receptor antagonist Substances 0.000 title abstract 2
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 206010047139 Vasoconstriction Diseases 0.000 abstract 1
- 208000030499 combat disease Diseases 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000025033 vasoconstriction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
A találmány tárgya (I) általános képletű endotelin-antagonistából -ahol R1 jelentése alkil-, alkoxicsoport: R2 jelentése alkil-,alkoxicsoport; R3 jelentése adott esetben fenilcsoporttalszubsztituált alkilcsoport, ahol a fenilcsoportot egy vagy kétalkoxicsoport szubsztituálhatja: Z jelentése oxigénatom vagy egyszereskémiai kötést kifejező vegyértékvonal -és egy bétareceptor-blokkolóbólálló kombináció. A kombináció vazokonstrikció okozta betegségekleküzdésére alkalmazható. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19743143A DE19743143A1 (de) | 1997-09-30 | 1997-09-30 | Pharmazeutische Kombinationspräparate |
PCT/EP1998/005772 WO1999016444A1 (de) | 1997-09-30 | 1998-09-10 | Endothelin-antagonist und betarezeptorenblocker als kombinationspräparate |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0004590A2 true HUP0004590A2 (hu) | 2001-11-28 |
HUP0004590A3 HUP0004590A3 (en) | 2002-01-28 |
HU226745B1 HU226745B1 (en) | 2009-09-28 |
Family
ID=7844115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004590A HU226745B1 (en) | 1997-09-30 | 1998-09-10 | Endothelin antagonist and beta receptor blocking agent as combined pharmaceutical preparations |
Country Status (17)
Country | Link |
---|---|
US (1) | US6352992B1 (hu) |
EP (1) | EP1019055B1 (hu) |
JP (1) | JP4608093B2 (hu) |
KR (1) | KR100623122B1 (hu) |
CN (1) | CN1149087C (hu) |
AT (1) | ATE239479T1 (hu) |
AU (1) | AU739860B2 (hu) |
BR (1) | BR9812404A (hu) |
CA (1) | CA2304698C (hu) |
CZ (1) | CZ298745B6 (hu) |
DE (2) | DE19743143A1 (hu) |
ES (1) | ES2199461T3 (hu) |
HK (1) | HK1032355A1 (hu) |
HU (1) | HU226745B1 (hu) |
NO (1) | NO319048B1 (hu) |
RU (1) | RU2213577C2 (hu) |
WO (1) | WO1999016444A1 (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
ES2262567T3 (es) | 2001-03-20 | 2006-12-01 | Schwarz Pharma Ag | Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico. |
PT1243263E (pt) | 2001-03-21 | 2003-03-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma |
KR20070007931A (ko) | 2004-04-16 | 2007-01-16 | 쉬바르츠파르마에이지 | 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도 |
JP2008510758A (ja) | 2004-08-27 | 2008-04-10 | シュヴァルツ・ファーマ・アーゲー | 骨肉腫の痛み、化学療法誘発性及びヌクレオシド誘発性の痛みを治療するためのペプチド化合物の新規使用 |
US20070196510A1 (en) * | 2006-02-17 | 2007-08-23 | Gerber Michael J | Method for treating resistant hypertension |
MX2008016000A (es) | 2006-06-15 | 2009-03-05 | Sanol Arznei Schwarz Gmbh | Composicion farmaceutica con efecto anticonvulsivante sinergistico. |
CA2697057A1 (en) | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
CN104887645B (zh) * | 2015-06-15 | 2016-12-14 | 吉林万通药业集团梅河药业股份有限公司 | 阿莫西林胶囊及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4786441A (en) * | 1987-08-24 | 1988-11-22 | International Business Machines Corporation | Preparation of iodonium and sulfonium triflates |
SE8704081D0 (sv) * | 1987-10-21 | 1987-10-21 | Haessle Ab | A new prohylactic method |
ATE189217T1 (de) | 1993-03-19 | 2000-02-15 | Merck & Co Inc | Phenoxyphenylessigsäurederivate |
EP0750608A1 (en) * | 1994-01-28 | 1997-01-02 | Cal International Limited | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
CA2206119C (en) * | 1994-12-12 | 2008-05-13 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain, inflammation and spasm |
NZ298853A (en) * | 1995-01-27 | 1998-07-28 | Rhone Poulenc Rorer Ltd | 5-[2-cyano-phenoxy]-2-phenyl-acetic acid derivatives |
DE19636046A1 (de) * | 1996-09-05 | 1998-03-12 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
DE19652374A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung |
WO1998027070A1 (de) * | 1996-12-18 | 1998-06-25 | Basf Aktiengesellschaft | Heterozyklische carbonsäurederivate, ihre herstellung und verwendung als endothelinrezeptorantagonisten |
-
1997
- 1997-09-30 DE DE19743143A patent/DE19743143A1/de not_active Withdrawn
-
1998
- 1998-09-10 US US09/508,989 patent/US6352992B1/en not_active Expired - Lifetime
- 1998-09-10 DE DE59808297T patent/DE59808297D1/de not_active Expired - Lifetime
- 1998-09-10 CA CA002304698A patent/CA2304698C/en not_active Expired - Fee Related
- 1998-09-10 KR KR1020007003346A patent/KR100623122B1/ko not_active IP Right Cessation
- 1998-09-10 RU RU2000111500/14A patent/RU2213577C2/ru not_active IP Right Cessation
- 1998-09-10 CZ CZ20001081A patent/CZ298745B6/cs not_active IP Right Cessation
- 1998-09-10 CN CNB988097273A patent/CN1149087C/zh not_active Expired - Fee Related
- 1998-09-10 AU AU92672/98A patent/AU739860B2/en not_active Ceased
- 1998-09-10 HU HU0004590A patent/HU226745B1/hu not_active IP Right Cessation
- 1998-09-10 BR BR9812404-8A patent/BR9812404A/pt active Search and Examination
- 1998-09-10 ES ES98945323T patent/ES2199461T3/es not_active Expired - Lifetime
- 1998-09-10 JP JP2000513580A patent/JP4608093B2/ja not_active Expired - Fee Related
- 1998-09-10 WO PCT/EP1998/005772 patent/WO1999016444A1/de active IP Right Grant
- 1998-09-10 AT AT98945323T patent/ATE239479T1/de active
- 1998-09-10 EP EP98945323A patent/EP1019055B1/de not_active Expired - Lifetime
-
2000
- 2000-03-29 NO NO20001634A patent/NO319048B1/no not_active IP Right Cessation
-
2001
- 2001-04-25 HK HK01102973A patent/HK1032355A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1272786A (zh) | 2000-11-08 |
CZ20001081A3 (en) | 2001-05-16 |
HU226745B1 (en) | 2009-09-28 |
EP1019055B1 (de) | 2003-05-07 |
EP1019055A1 (de) | 2000-07-19 |
CA2304698C (en) | 2008-02-19 |
NO20001634D0 (no) | 2000-03-29 |
BR9812404A (pt) | 2000-09-19 |
ES2199461T3 (es) | 2004-02-16 |
AU739860B2 (en) | 2001-10-25 |
CZ298745B6 (cs) | 2008-01-16 |
NO20001634L (no) | 2000-03-29 |
JP2001517703A (ja) | 2001-10-09 |
US6352992B1 (en) | 2002-03-05 |
ATE239479T1 (de) | 2003-05-15 |
WO1999016444A1 (de) | 1999-04-08 |
RU2213577C2 (ru) | 2003-10-10 |
CA2304698A1 (en) | 1999-04-08 |
DE59808297D1 (de) | 2003-06-12 |
KR100623122B1 (ko) | 2006-09-12 |
HUP0004590A3 (en) | 2002-01-28 |
KR20010015650A (ko) | 2001-02-26 |
NO319048B1 (no) | 2005-06-06 |
JP4608093B2 (ja) | 2011-01-05 |
AU9267298A (en) | 1999-04-23 |
CN1149087C (zh) | 2004-05-12 |
HK1032355A1 (en) | 2001-07-20 |
DE19743143A1 (de) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9203165A (es) | Derivados de succinimida y composicion farmaceutica que los contiene . | |
CY1110243T1 (el) | Ανταγωνιστες npyy5 | |
ATE296821T1 (de) | Triarylimidazol-derivate als cytokin-inhibitoren | |
TR200200778T2 (tr) | Pirazol türevleri. | |
TR199902203T2 (xx) | Fernesil transferaz engelleyici, N-veya C-ba�lant�l� imidazoller ile ikame edilmi� 1,8-anele kinolinon t�revleri. | |
HUP0500610A2 (hu) | Indazol-, benzotiazol- és benzoizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
HUP0402352A2 (hu) | Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP0400757A2 (hu) | Protein kináz gátló hatású kondenzált pirazolszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
YU16899A (sh) | Aralkil i aralkiliden heterociklicni laktami i imidi | |
TR199902606T2 (xx) | Farnesil transferaz� engelleyici kinazolinonlar. | |
ATE228507T1 (de) | Substituierte 6-phenylphenanthridine | |
ES2154270T3 (es) | Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas. | |
BR0108816A (pt) | Derivados de quinolina como antagonistas alfa-2 | |
PT869946E (pt) | Fenilimidazolidinas e sua utilizacao como agentes anti-androgenicos | |
DE60101372D1 (de) | Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität | |
HUP0004590A2 (hu) | Endotelin-antagonista imidazolszármazékokat és béta receptor blokkolókat tartalmazó kombinációs gyógyszerkészítmények | |
HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
BR0208205A (pt) | Derivados de benzimidazol moduladores de receptores de quimocinas | |
HUP0303038A2 (hu) | Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
ES2175405T3 (es) | Derivados de adenosina. | |
HUP0303204A2 (hu) | 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP9800817A2 (hu) | Halogén-alk(en)oxi-szubsztituenseket tartalmazó szulfonil-amino-karbonil-triazolinon-származékok, intermedierjeik, előállításuk és alkalmazásuk, hatóanyagként ezeket a vegyületeket tartalmazó herbicid vagy fungicid készítmények | |
HRP20010630B1 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists | |
HUP9800820A2 (hu) | Halogén-alk(en)il-tio-szubsztituenseket tartalmazó szulfonil-amino-karbonil-triazolinon-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid vagy fungicid készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETKOEZI SZABADALMI IRODA, HU Representative=s name: DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEG, HU |
|
FH92 | Termination of representative |
Representative=s name: BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETK, HU |
|
GB9A | Succession in title |
Owner name: ABBVIE DEUTSCHLAND GMBH & CO KG, DE Free format text: FORMER OWNER(S): KNOLL AKTIENGESELLSCHAFT, DE; ABBOTT GMBH & CO. KG, DE |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |